Avaliação endócrino metabólica, massa óssea e sarcopenia em pacientes submetidos a quimioterapia em alta dose pós transplante autólogo de células tronco hematopoiéticas por linfoma
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Introduction: In the universe of patients with lymphoma, the recurrence rate
after initial chemotherapy is around 30%, with autologous stem cell
transplantation being the standard therapy after relapse. It is known the effort
to improve the patient’s quality of life, due to the increase in overall survival and
progression-free survival. However, there are relevant outcomes during follow
up like endocrine, metabolic, body composition and bone complications and
these population have a special condition, is often young.
Objective: To evaluate the long-term endocrine, metabolic, bone mass, sarcopenia
and symptoms of anxiety, depression and stress complications in patients
transplanted for lymphoma, who underwent high-dose chemotherapy in the
conditioning regimen prior to transplantation.
Material and methods: This is a cross-sectional study with patients
transplanted for lymphoma over 18 years old. They were invited to participate
through telephone contact and attended the University Hospital for laboratory
tests, medical evaluation, complementary tests such as bone density and total
body composition assessment, in addition to the self-filling of the DASS 21
scale.
Results: A total of 39 patients were recruited with a median follow-up time of 30
months (2-180 months), with 25 (64.1%) transplanted for Hodgkin lymphoma.
A prevalence similar to that of the Brazilian population was found regarding
metabolic comorbidities like diabetes (10.2%), obesity (30.7%) and metabolic
syndrome (33.3%). Regarding hormonal changes in women,
hypergonadotropic hypogonadism occurred in 70% of those in menarche time,
with a median amenorrhea period of 12 months (2-172 months). As for men,
infertility, related to treatment, was significant and observed through the
measurement of FSH gonadotropin above the upper limit of the method in
81.2% (13 patients). The assessment of sarcopenia was performed according
to the updated criteria of the European EWGSOP2 group through total body
densitometry, with a frequency found of 15.4%, however, it affected only patients
transplanted from 2019 onwards with no severe sarcopenia or sarcopenic
obesity. Bone mass changes occurred in 23% (9 patients) in both sexes, however
without a history of fragility fractures. Regarding the assessment of the
psychological profile, it was carried out through screening using the DASS 21
tool, compared to a control group, that are hematological patients without
oncological pathologies however, this group showed significantly anxiety
symptoms superior to the transplanted group (p=0.023) and, of the 7 patients
who were in treatment for depression, all scored for it on the DASS 21.
Conclusion: With the advances in the therapy of patients with lymphoma,
survival has been progressively increasing and likewise l o n g t e r m
c o m p l i c a t i o n s . Furthermore, there is a highlighting importance of
multidisciplinary follow-up and screening of major modifiable risk factors such
as overweight, muscle strength, hyperglycemia, hypertension, dyslipidemia,
sedentary lifestyle and metabolic syndrome.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

